Keros Announces U.S. FDA Orphan Drug Designation Granted to KER-065 for the Treatment of Duchenne Muscular Dystrophy
August 20, 2025 09:48 ET | Source: Keros Therapeutics, Inc. LEXINGTON, Mass.,…
U.S. Oral Surgery Management Moves into 31st State
IRVING, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management…
GameChange Solar Rises to Third Globally and Second in U.S. Solar Tracker Market
NORWALK, Conn., Aug. 12, 2025 /PRNewswire/ -- GameChange Solar has solidified its…
DERMALOG JENETRIC Introduces Mobile Palm Scanner LIVETOUCH PALM to the U.S. Market
At the 2025 IAI Conference in Orlando, DERMALOG JENETRIC will debut the…
Zenara Pharma Receives U.S. FDA Approval for First Generic of Sertraline Hydrochloride Capsules with 180-Day CGT Exclusivity
HYDERABAD, India, August 1, 2025 /PRNewswire/ -- Zenara Pharma Private Limited ("Zenara"), a Biophore…
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in…
NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion
July 29, 2025 09:00 ET | Source: NewGenIvf Limited The new cytometry…
Radware Expands U.S. Presence with New Managed Security Service Provider Partnerships
MAHWAH, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a…
FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE
Key Takeaways Two lifestyle interventions in U.S. POINTER improved cognition in older…
CGTN: How China’s economy remains vibrant despite U.S. tariff war
BEIJING, July 28, 2025 /PRNewswire/ -- With Chinese Vice Premier He Lifeng to…
